Target intelligence / Profile preview

Immunoglobulin heavy variable 1-24 (IGHV1-24)

Target
IGHV1-24
Molecular classification
Immunoglobulin variable region, Antibody fragment, Other
01

Overview

Immunoglobulin heavy variable 1-24 (IGHV1-24) encodes the variable region of the heavy chain of human immunoglobulins, which are crucial for antigen recognition in the humoral immune response. The variable region is assembled by V-(D)-J recombination and can undergo somatic hypermutation to increase affinity for specific antigens. IGHV genes, including IGHV1-24, are highly polymorphic and contribute to the diversity of antibodies, enabling recognition of a wide range of pathogens. IGHV1-24 is not a receptor, enzyme, or druggable therapeutic target itself; rather, it is a genetic component that forms part of the variable region in antibodies produced by B cells. Variation in IGHV family genes (including IGHV1-24) impacts the adaptive immune response, and allelic differences may influence susceptibility to infection, autoimmune disease, and the body’s ability to generate effective antibody repertoires. IGHV1-24 does not have approved drugs or well-established biomarkers directly linked to its function.

Other names
IGHV1-24IGHV124Immunoglobulin heavy variable 1-24VHImmunoglobulin heavy chain variable regionimmunoglobulin heavy chain variable 1-24
02

Mechanism of action

Not applicable

03

Biological functions

Antigen bindingAdaptive immune responseHumoral immunityImmunoglobulin-mediated immune response
04

Disease associations

InfectionAutoimmunityOther (diversity in IGHV alleles linked to susceptibility & variability in immune-related diseases, though specific associations with IGHV1-24 are not clearly documented)
05

Safety considerations

None specific; general antibody-mediated safety concerns (e.g., off-target reactivity, immunogenicity) do not directly pertain to IGHV1-24 as an isolated gene region
06

Interacting drugs

None
07

Biomarkers

None specific for IGHV1-24; in research, IGHV gene usage, diversity, and rearrangement are used in immune repertoire profiling, clonal tracking, and some disease diagnostics, but IGHV1-24 is not a standard biomarker

Beyond the preview

Go deeper on Immunoglobulin heavy variable 1-24 (IGHV1-24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 1-24 (IGHV1-24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call